Terms: = Skin cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
158 results:
1. B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma.
Shen B; Mei J; Xu R; Cai Y; Wan M; Zhou J; Ding J; Zhu Y
Pathol Res Pract; 2024 Apr; 256():155267. PubMed ID: 38520953
[TBL] [Abstract] [Full Text] [Related]
2. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hypoxic-related lncRNAs prognostic model for revealing clinical prognostic and immune infiltration characteristic of cutaneous melanoma.
Liao C; Yang J; Chen L; Ye Z
Aging (Albany NY); 2024 Feb; 16(4):3734-3749. PubMed ID: 38364250
[TBL] [Abstract] [Full Text] [Related]
4. Emilin2 fosters vascular stability by promoting pericyte recruitment.
Fejza A; Camicia L; Carobolante G; Poletto E; Paulitti A; Schinello G; Di Siena E; Cannizzaro R; Iozzo RV; Baldassarre G; Andreuzzi E; Spessotto P; Mongiat M
Matrix Biol; 2023 Sep; 122():18-32. PubMed ID: 37579864
[TBL] [Abstract] [Full Text] [Related]
5. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract] [Full Text] [Related]
6. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
[TBL] [Abstract] [Full Text] [Related]
7.
Ibáñez-Molero S; van Vliet A; Pozniak J; Hummelink K; Terry AM; Monkhorst K; Sanders J; Hofland I; Landeloos E; Van Herck Y; Bechter O; Kuilman T; Zhong W; Marine JC; Wessels L; Peeper DS
Oncoimmunology; 2022; 11(1):2139074. PubMed ID: 36465485
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
9. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
[TBL] [Abstract] [Full Text] [Related]
10. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Arkhypov I; Özbay Kurt FG; Bitsch R; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X; Li W; Utikal J; Altevogt P; Umansky V
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113897
[TBL] [Abstract] [Full Text] [Related]
11. MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling.
Shen Q; Han Y; Wu K; He Y; Jiang X; Liu P; Xia C; Xiong Q; Liu R; Chen Q; Zhang Y; Zhao S; Yang C; Chen Y
Signal Transduct Target Ther; 2022 May; 7(1):147. PubMed ID: 35504869
[TBL] [Abstract] [Full Text] [Related]
12. HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.
Shao XM; Huang J; Niknafs N; Balan A; Cherry C; White J; Velculescu VE; Anagnostou V; Karchin R
Ann Oncol; 2022 Jul; 33(7):728-738. PubMed ID: 35339648
[TBL] [Abstract] [Full Text] [Related]
13. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
Bitsch R; Kurzay A; Özbay Kurt F; De La Torre C; Lasser S; Lepper A; Siebenmorgen A; Müller V; Altevogt P; Utikal J; Umansky V
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35301236
[TBL] [Abstract] [Full Text] [Related]
14. Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.
Straub Hogan MM; Spieker AJ; Orejudos M; Gheit T; Herfs M; Tommasino M; Sanchez DF; Fernandez-Nestosa MJ; Pena MDCR; Gordetsky JB; Epstein JI; Canete-Portillo S; Gellert LL; Prieto Granada CN; Magi-Galluzzi C; Cubilla AL; Giannico GA
Mod Pathol; 2022 Aug; 35(8):1101-1109. PubMed ID: 35190664
[TBL] [Abstract] [Full Text] [Related]
15. B cell-related gene signature and cancer immunotherapy response.
Lundberg A; Li B; Li R
Br J Cancer; 2022 Apr; 126(6):899-906. PubMed ID: 34921229
[TBL] [Abstract] [Full Text] [Related]
16. Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using
Fukuda H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831103
[TBL] [Abstract] [Full Text] [Related]
17. Mathematical model of a personalized neoantigen cancer vaccine and the human immune system.
Rodriguez Messan M; Yogurtcu ON; McGill JR; Nukala U; Sauna ZE; Yang H
PLoS Comput Biol; 2021 Sep; 17(9):e1009318. PubMed ID: 34559809
[TBL] [Abstract] [Full Text] [Related]
18. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options.
Gehrcken L; Sauerer T; Schaft N; Dörrie J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445385
[TBL] [Abstract] [Full Text] [Related]
19. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Martini C; DeNichilo M; King DP; Cockshell MP; Ebert B; Dale B; Ebert LM; Woods A; Bonder CS
BMC Cancer; 2021 Jul; 21(1):765. PubMed ID: 34215227
[TBL] [Abstract] [Full Text] [Related]
20. Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Bennardo L; Bennardo F; Giudice A; Passante M; Dastoli S; Morrone P; Provenzano E; Patruno C; Nisticò SP
Curr Oncol; 2021 Jun; 28(4):2317-2325. PubMed ID: 34201867
[No Abstract] [Full Text] [Related]
[Next]
